QuickBird Medical has won the Europe-wide tender of the German Sport University Cologne for the EVIGAIN project (“Evidence-based management with AI-supported clinical decision-making in primary care systems”). The project is creating a platform that uses AI to support medical and therapy practices in the care of noncommunicable diseases, above all obesity. QuickBird Medical is further developing a first version created by the university.
The platform:
- includes a practice application for treatment plans and an app for patients
- combines AI services with an evidence-based knowledge base
- runs in a C5-attested cloud and is designed for the GDPR and the EU AI Act
The client is the Institute of Movement and Neurosciences at the German Sport University Cologne, Germany’s only sports university. The project is funded by Novo Nordisk Pharma GmbH. With EVIGAIN, AI is intended to support evidence-based obesity treatment in practice.
Announcement by QuickBird Medical: EVIGAIN tender won (in German)